lecture 10 - - Neurodegnerative disease, Vascular Dementia, and Prion Disease Flashcards
Prion Disease -- how common? Three forms? Which is the most common form? Biochemistry of the disease
1-2 cases per Million per years
Three forms: Familial, Sporadic, transmitted
Most common: Sporadic
Biochem: PRPC protein –> PRPSC which forms abnormal beta sheets resistant to proteases
Two human forms of prion disease and associated pathology?
Cruetzfeldt Jakob Disease –
Variant Form CJD
CJD
pathology?
Median Survival?
Manifestations?
Variant CJD – how is it acquired ?
CJD:
Spongiform Degeneration of the gray matter with vaculoization –
Rapidly progressive (median survival 3.5 months) of dementia and startle myoclonus
Variant CJD – thought be acquired through contaminated beef
What are the synucleinopathies ?
PD
LBD
Multiple System Atrophy
What are the Tauopathies ?
what other disease?
Fronto-Temporal Dementia (Pick’s Disease, FTDP-17)
PSP – Progressive Supranuclear Palsy
Corticobasal Degeneration
(ALZ – tangles = tau; senile plaques = beta)
what is vascular dementia?
what are the three subtypes
Vascular dementia – Brain injury from vascular insufficeincy/ischemia/HTN
Step wise progression rather than gradual decline
Subtypes:
Multiple Infarct Dementia
Biswanger’s Disease
CADASIL –
CADASIL
stands for?
associated mutation?
Pathological changes?
how is a dx typically conducted?
Cerebral Autosomal Dominant Angiopathy w/ Subcortical Infarcts and Leukoencephalopathy
(CVD and white matter damage)
Molecular – Notch 3 Mutation
Sclerotic Changes, which can also be present on the skin (therefore skin bx is taken for Dx)
Binswangers
white matter degeneration secondary to vascular disease (small artery sclerosis)
alz -- histopath findings Imaging pathogenesis potential treatments
Tau Tangles; Beta Amyloid Senile Plaques
Imaging: Ventricular englargement with Sulcal Widening
Pathogensis: ApoE4 increased risk for development;
Mutated genes for Presnelin 1 and 2 – involved in metabolism of Beta Amyloid
Plaques = A-Beta Fragement of the Beta Amyloid
Tx - Increased ACH
Cholinesterase Inhibitors –
NMDA Antagonist – Memantine (neuroprotective)
PD –
Gross path
Micropath
What are parkinsonisms?
Possible treatment
Gross Path – loss of pigment of the SN
Micropath – Lewy Bodies in the SN
Loss of dopaminergic neurons
Parkinsonism – Bradykinesia, Unilateral tremor, ridigity
Treatments: LevoDopa with dopamine metabolizing enzyme inhibitor (Carbidopa)
Other treatments – MAOIs (block dopamine reuptake); COMT inhibitors; Dopamine Agonists
Lewy Body Dementia –
how does it differ from PD
Clinical onset for LBD: dementia first, then parkinsonisms
PD: Parkinsonism first
Multiple System Atrophy –
what 3 regions are damaged and how does the damage manifest
where does the synulcein accumulate?
SN – dopamine loss = Parkisonisms
Olivopontocerebellar damage = ataxia
Preganglionic Neuron Autonomic Loss = Shy drager autonomic loss
Synuclein accumulates in oligodendrocytes (not neurons like PD)
Tauopathies:
Fronto temporal dementia (Picks and FTD-Parkinsonism Chr 17)
Progressive Supranuclear Palsy
Corticobasilar Degeneration
What are the Frontotemporal Dementias –
how do they manifest ?
Pick’s and FTDP_Chr17
Language dysfunction, personality changes, memory loss , dementia
Pick’s Disease –
Characterisitic pathology?
Tau positive Pick bodies; ballooned neurons